Diabetes mellitus and genetically programmed defects in β-cell function

Nature

Volumn 414, Issue 6865, 2001, Pages 788-791

  Bell, Graeme I ^a   Polonsky, Kenneth S ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DEVELOPING COUNTRIES; GENES; INSULIN; MUTAGENESIS; TISSUE;

CELL FUNCTIONS;

GENETIC ENGINEERING;

INSULIN;

DIABETES; GENETICS;

DEVELOPED COUNTRY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN METABOLISM; INSULIN RELEASE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; ISLETS OF LANGERHANS;

EID: 0035856943     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/414788a     Document Type: Review

References (59)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus
2. Type 1 diabetes: New perspective on disease pathogenesis and treatment
3. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance
4. The importance of β-cell failure in the development and progression of type 2 diabetes
5. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
6. Maturity-onset diabetes of the young: From clinical description to molecular genetic characterization
7. Genetically defined forms of diabetes in children
8. Dominant negative mutations in human PPAR associated with severe insulin resistance, diabetes mellitus and hypertension
9. Neonatal diabetes mellitus due to complete glucokinase deficiency
10. Liver-enriched transcription factors and hepatocyte differentiation
11. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF) 1 and HNF 4 families: Functional and pathological consequences
12. Hepatocyte nuclear factor la is expressed in a hamster insulinoma line and transactivates the rat insulin I gene
13. Human insulin gene is a target gene of hepatocyte nuclear factor-1α (HNF-1α) and HNF-1β
14. Molecular targets of a HNF1α mutation responsible for pancreatic β-cell dysfunction
15. Hepatocyte nuclear factor 4α regulates the expression of pancreatic β-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion
16. Loss of HNF-1α function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism
17. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4α/MODYI gene
18. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice
19. Insulin-promoter-factor 1 is required for pancreas development in mice
20. Transcribing diabetes
21. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF 1 gene coding sequence
22. Purification of the β-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells
23. Early-onset type-II diabetes mellitus (MODY4) linked to 1PF1
24. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
25. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus
26. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene)
27. BETA2 and pancreatic islet development
28. Mutations in NEUROD 1 are associated with the development of type 2 diabetes mellitus
29. Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history
30. Maternally inherited diabetes and deafness: A new diabetes subtype
31. Leu(UUR) gene mutation
32. Impaired insulin secretion and β-cell loss in tissue-specific knockout mice with mitochondrial diabetes
33. Type 2 diabetes mellitus in children
34. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat
35. Pancreatic β-cells in obesity. Evidence for induction of functional, morphological, and metabolic abnormalities by increased long chain fatty acids
36. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity and the onset of diabetes
37. Using β-cell growth factors to enhance human pancreatic islet transplantation
38. Evidence for a circulating islet growth factor in insulin-resistant states
39. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt/PKBα
40. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diabetes
41. Prolonged elevation of plasma free fatty acids impairs pancreatic β-cell function in obese nondiabetic, human but not in individuals with type 2 diabetes
42. The common PPAR-Pro 12Ala polymorphism is associated with decreased risk of type 2 diabetes
43. Evidence for gene-nutrient interaction at the PPAR-locus
44. 2 gene
45. Treatment of insulin resistance with peroxisome proliferator-activated receptor agonists
46. Treatment with the oral antidiabetic agent troglitazone improves β cell responses to glucose in subjects with impaired glucose tolerance
47. Expression of the peroxisome proliferator-activated receptor (PPAR) in normal human pancreatic islets
48. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes
49. Selective insulin signaling through A and B insulin receptors regulates transcription of the insulin and glucokinase genes in pancreatic β cells
50. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
51. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
52. Calpains play a role in insulin secretion and action
53. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): Analysis of 573 pedigrees provides independent replication of a locus on chromosome 1q
54. Noninvasive in vivo measurement of β-cell mass in mouse model of diabetes
55. ATP channels learned from Kir6.2 genetically engineered mice